Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Decreased monocyte-mediated angiogenesis in scleroderma.

A E Koch1, M A Litvak, J C Burrows

  • 1Department of Medicine, Northwest University Medical School, Chicago, Illinois.

Clinical Immunology and Immunopathology
|August 1, 1992
PubMed
Summary

Scleroderma patients' monocytes show reduced angiogenic activity when stimulated, suggesting altered activation markers may contribute to the disease's vascular issues.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A History of Innovations in the Diagnosis and Treatment of Oral and Head and Neck Cancer.

Journal of dental research·2019
Same author

Precision Therapy of Head and Neck Squamous Cell Carcinoma.

Journal of dental research·2018
Same author

Expanding the Research Capacity of Dental Schools: Are We There Yet?

Journal of dental research·2016
Same author

Experimental sadness induces relevant interactions between central endogenous opioid activation and plasma IL-18 concentrations in depressed volunteers.

Molecular psychiatry·2016
Same author

Acute experimental changes in mood state regulate immune function in relation to central opioid neurotransmission: a model of human CNS-peripheral inflammatory interaction.

Molecular psychiatry·2015
Same author

Clinical application of genetics to guide prevention and treatment of oral diseases.

Clinical genetics·2014

Area of Science:

  • Immunology
  • Vascular Biology
  • Dermatology

Background:

  • Scleroderma is characterized by abnormal blood vessel growth.
  • Monocytes/macrophages are implicated in the vascular lesions of scleroderma.

Purpose of the Study:

  • To investigate the angiogenic potential of monocytes from scleroderma patients.
  • To explore monocyte activation markers in scleroderma.

Main Methods:

  • Monocytes were isolated from scleroderma patients and healthy controls.
  • Monocyte-conditioned media were tested for angiogenesis using a rat corneal bioassay.
  • Cell surface activation markers on monocytes were analyzed via radioimmunoassay.

Main Results:

  • LPS-stimulated scleroderma monocytes exhibited significantly less angiogenic activity compared to normal monocytes.

Related Experiment Videos

  • Tumor necrosis factor-alpha levels did not differ between groups.
  • Scleroderma monocytes showed altered binding of activation markers (HLA-DR, 8D7) after interferon-gamma stimulation.

    • Conclusions:

    • Scleroderma monocytes display impaired angiogenic potential upon stimulation.
    • Aberrant monocyte activation markers may play a role in scleroderma's vascular pathology.
    • These findings suggest a potential contribution of monocyte dysfunction to scleroderma's vascular proliferation.